Noerr advises ODDO SEDYLER on IPO of BRAIN AG

Noerr has advised ODDO SEYDLER BANK AG on the initial public offering of B.R.A.I.N. Biotechnology Research and Information Network AG. ODDO SEYDLER coordinated the transaction as the sole global coordinator and sole bookrunner. BRAIN AG is the first biotechnology company to go public on a German stock exchange in ten years.

The BRAIN securities will start trading on the regulated market (prime standard) of the Frankfurt Stock Exchange on 9 February 2016. Based on the issue price of 9 euros, the entire placement volume including over-allotment is approx. EUR 32.5 million. The company will receive proceeds from the issue of EUR 31.5 million.

BRAIN AG is among the technologically leading biotechnology businesses in Europe. Based in the German town of Zwingenberg, the company offers solutions and products that are used in many industry sectors, including the chemicals, consumer products, cosmetics, animal feed and food products industries.

Only recently, Noerr advised ODDO SEYDLER on the successful IPO of Deutsche Konsum Grundbesitz REIT AG and also assisted the Modern Dental Group, one of the world’s leading dental laboratories, on its successful IPO at the Hong Kong Stock Exchange. In addition, teams of Noerr were involved in the run-up to the IPOs of Rocket Internet SE and Zalando SE.

Advisors to ODOD SEYDLER Bank AG: Noerr LLP

Dr. Stephan Schulz, Dr. Laurenz Wieneke (both lead), Dr. Holger Alfes (all Capital Markets), Dr. Maximilian Uibeleisen (Regulatory);

Associate: Dr. Ivan Zlatanov (Capital Markets, all Frankfurt)